Found 5 matching trials
Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis PHASE2 The purpose of this study is to assess the efficacy of two doses of subling...
Show More Location
Multiple Locations
Learn More & Join Trial
Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction PHASE2 The primary objective of this study is to assess whether the combination of...
Show More Location
Royal Brompton Hospital
Learn More & Join Trial
Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis PHASE3 To investigate the immunologic effects and safety of 60-day treatment of th...
Show More Location
Research facility ID ORG-001086
Learn More & Join Trial
Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study PHASE2 About 45 million people in Europe have allergic rhinitis (hay fever) - infl...
Show More Location
NHS Royal Brompton Hospital
Learn More & Join Trial
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber PHASE3 This trial evaluates the efficacy and safety of HDM SLIT-tablet in treatmen...
Show More Location
Vienna Challenge Chamber
Learn More & Join Trial